• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环磷酸腺苷和环磷酸鸟苷磷酸二酯酶抑制剂对豚鼠腹腔巨噬细胞超氧爆发的影响。

The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages.

作者信息

Turner N C, Wood L J, Burns F M, Gueremy T, Souness J E

机构信息

Dagenham Research Centre, Rhone-Poulenc Rorer Ltd., Dagenham, Essex.

出版信息

Br J Pharmacol. 1993 Apr;108(4):876-83. doi: 10.1111/j.1476-5381.1993.tb13481.x.

DOI:10.1111/j.1476-5381.1993.tb13481.x
PMID:8387385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1908157/
Abstract
  1. The cyclic nucleotide phosphodiesterase (PDE) activity of guinea-pig peritoneal macrophages was partially characterized and the effects of selective and non-selective inhibitors of adenosine 3':5'-cyclic monophosphate (cyclic AMP PDE) and guanosine 3':5'-cyclic monophosphate (cyclic GMP PDE) phosphodiesterases on superoxide generation were investigated using peritoneal macrophages from horse-serum pretreated guinea-pigs. 2. The non-selective PDE inhibitor, 3-isobutyl-1-methylxanthine (IBMX) and the PDE I/V selective inhibitor, zaprinast, inhibited spontaneous superoxide generation with IC50s of 30.7 +/- 11.3 microM and 145 +/- 17 microM respectively (n = 6 and 5). The concentration-response curves for the PDE IV selective inhibitors rolipram and Ro20-1724 were biphasic; mean maximum inhibitions were 56.9 +/- 5.9% and 66.8 +/- 10.5% respectively at 300 microM, but in 2 out of 6 (rolipram) and 2 out of 5 (Ro20-1724) experiments inhibition was < 50%. The PDE III inhibitor SK&F 94120 was without effect. Spontaneous superoxide generation was reduced 57 +/- 10% by 1 microM prostaglandin E2 (PGE2) and 62.6 +/- 3.76% by 1 microM salbutamol. 3. The increase in superoxide generation elicited by FMLP (10(-9)-10(-5)M) was unaffected by any of the PDE inhibitors studied. Inhibition of FMLP-stimulated superoxide generation by PGE2 was enhanced in the presence of 10 microM IBMX. 4. Macrophages were found to contain a predominantly membrane bound cyclic AMP PDE (90% of total activity) which was unaffected by cyclic GMP or calcium/calmodulin. The cyclic AMP PDE activity in the cytosolic fraction was enhanced in the presence of calcium/calmodulin. Selective inhibitors of PDE IV inhibited the particulate cyclic AMP PDE activity (IC50s rolipram 1.5 +/- 0.3 microM, Ro 20-17244.1 +/- 0.6 microm) as did the non-selective inhibitor IBMX (IC50 22 +/- 8 microM). The macrophage particulate PDE activity was resistant to inhibition by the PDE III inhibitor SK&F 94836 and the PDE I/V inhibitor, zaprinast. The cytosolic calcium/calmodulin stimulated cyclic AMP hydrolytic activity was inhibited by zaprinast (IC50 - calcium/calmodulin 123 +/- 39 microM; + calcium/calmodulin IC50 17.7 +/- 6.3 microM).5. The results indicate that guinea-pig peritoneal macrophages contain a type IV cyclic AMP PDE which is predominantly membrane associated and a predominantly cytosolic calcium/calmodulin stimulated cyclic AMP PDE. Functional studies suggest that both of these PDE activities contribute to cyclic AMP hydrolysis and regulation of superoxide generation in these cells. Inhibition of spontaneous superoxide generation, but not that stimulated by FMLP, suggests that the activity of PDE inhibitors is subject to functional antagonism but that this can be overcome by enhancing cyclic AMP formation.
摘要
  1. 对豚鼠腹腔巨噬细胞的环核苷酸磷酸二酯酶(PDE)活性进行了部分特性鉴定,并使用经马血清预处理的豚鼠的腹腔巨噬细胞,研究了腺苷3':5'-环一磷酸(环磷酸腺苷PDE)和鸟苷3':5'-环一磷酸(环磷酸鸟苷PDE)磷酸二酯酶的选择性和非选择性抑制剂对超氧化物生成的影响。2. 非选择性PDE抑制剂3-异丁基-1-甲基黄嘌呤(IBMX)和PDE I/V选择性抑制剂扎普司特抑制自发超氧化物生成,IC50分别为30.7±11.3微摩尔和145±17微摩尔(n = 6和5)。PDE IV选择性抑制剂咯利普兰和Ro20-1724的浓度-反应曲线呈双相;在300微摩尔时,平均最大抑制率分别为56.9±5.9%和66.8±10.5%,但在6个实验中的2个(咯利普兰)和5个实验中的2个(Ro20-1724)中,抑制率<50%。PDE III抑制剂SK&F 94120无作用。1微摩尔前列腺素E2(PGE2)使自发超氧化物生成减少57±10%,1微摩尔沙丁胺醇使其减少62.6±3.76%。3. FMLP(10^(-9)-10^(-5)M)引起的超氧化物生成增加不受所研究的任何PDE抑制剂影响。在10微摩尔IBMX存在下,PGE2对FMLP刺激的超氧化物生成的抑制作用增强。4. 发现巨噬细胞主要含有一种与膜结合的环磷酸腺苷PDE(占总活性的90%),其不受环磷酸鸟苷或钙/钙调蛋白影响。在钙/钙调蛋白存在下,胞质部分的环磷酸腺苷PDE活性增强。PDE IV的选择性抑制剂抑制颗粒状环磷酸腺苷PDE活性(咯利普兰的IC50为1.5±0.3微摩尔,Ro 20-172 的IC50为4.1±0.6微摩尔),非选择性抑制剂IBMX(IC50为22±8微摩尔)也有此作用。巨噬细胞颗粒状PDE活性对PDE III抑制剂SK&F 94836和PDE I/V抑制剂扎普司特的抑制有抗性。扎普司特抑制胞质钙/钙调蛋白刺激的环磷酸腺苷水解活性(钙/钙调蛋白存在时IC50为123±39微摩尔;钙/钙调蛋白存在时IC50为17.7±6.3微摩尔)。5. 结果表明,豚鼠腹腔巨噬细胞含有一种主要与膜相关的IV型环磷酸腺苷PDE和一种主要位于胞质的钙/钙调蛋白刺激的环磷酸腺苷PDE。功能研究表明,这两种PDE活性均有助于这些细胞中环磷酸腺苷的水解和超氧化物生成的调节。对自发超氧化物生成的抑制而非对FMLP刺激的超氧化物生成的抑制表明,PDE抑制剂的活性受到功能拮抗作用,但可通过增强环磷酸腺苷的形成来克服。

相似文献

1
The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages.环磷酸腺苷和环磷酸鸟苷磷酸二酯酶抑制剂对豚鼠腹腔巨噬细胞超氧爆发的影响。
Br J Pharmacol. 1993 Apr;108(4):876-83. doi: 10.1111/j.1476-5381.1993.tb13481.x.
2
Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.豚鼠巨噬细胞中磷酸二酯酶4的特性:多种活性、缔合状态及对选择性抑制剂的敏感性
Br J Pharmacol. 1998 May;124(1):129-40. doi: 10.1038/sj.bjp.0701819.
3
Inhibition of pig aortic smooth muscle cell DNA synthesis by selective type III and type IV cyclic AMP phosphodiesterase inhibitors.选择性III型和IV型环磷酸腺苷磷酸二酯酶抑制剂对猪主动脉平滑肌细胞DNA合成的抑制作用
Biochem Pharmacol. 1992 Sep 1;44(5):857-66. doi: 10.1016/0006-2952(92)90116-z.
4
Characterization of guinea-pig eosinophil phosphodiesterase activity. Assessment of its involvement in regulating superoxide generation.豚鼠嗜酸性粒细胞磷酸二酯酶活性的表征。评估其在调节超氧化物生成中的作用。
Biochem Pharmacol. 1991 Jul 25;42(4):937-45. doi: 10.1016/0006-2952(91)90056-b.
5
Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.猪主动脉内皮细胞环核苷酸磷酸二酯酶。使用磷酸二酯酶抑制剂评估它们在完整细胞中调节环核苷酸水平的作用。
Biochem J. 1990 Feb 15;266(1):127-32. doi: 10.1042/bj2660127.
6
Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.从肝脏和肝细胞中分离出可溶性环核苷酸磷酸二酯酶同工酶,鉴定出一种新型的对异丁基甲基黄嘌呤(IBMX)不敏感的形式。
Biochem Pharmacol. 1989 Nov 15;38(22):4123-36. doi: 10.1016/0006-2952(89)90694-1.
7
Effects of SCA40 on human isolated bronchus and human polymorphonuclear leukocytes: comparison with rolipram, SKF94120 and levcromakalim.SCA40对人离体支气管和人多形核白细胞的作用:与咯利普兰、SKF94120和左旋克罗卡林的比较。
Br J Pharmacol. 1996 Sep;119(1):99-106. doi: 10.1111/j.1476-5381.1996.tb15682.x.
8
Cyclic nucleotide phosphodiesterases from frog atrial fibers: isolation and drug sensitivities.青蛙心房纤维中的环核苷酸磷酸二酯酶:分离与药物敏感性
Am J Physiol. 1992 Mar;262(3 Pt 2):H654-60. doi: 10.1152/ajpheart.1992.262.3.H654.
9
Investigation of the inhibitory effects of PGE2 and selective EP agonists on chemotaxis of human neutrophils.前列腺素E2(PGE2)和选择性EP激动剂对人中性粒细胞趋化性抑制作用的研究。
Br J Pharmacol. 1995 Dec;116(7):2903-8. doi: 10.1111/j.1476-5381.1995.tb15943.x.
10
Relaxation of guinea-pig trachea by cyclic AMP phosphodiesterase inhibitors and their enhancement by sodium nitroprusside.环磷酸腺苷磷酸二酯酶抑制剂对豚鼠气管的舒张作用及其被硝普钠增强的作用
Br J Pharmacol. 1994 Apr;111(4):1047-52. doi: 10.1111/j.1476-5381.1994.tb14850.x.

引用本文的文献

1
Preventive effect of zaprinast and 3-isobutyl, 1-methylxanthine (phosphodiesterase inhibitors) on gastric injury induced by nonsteroidal antiinflammatory drugs in rats.扎普司特和3-异丁基-1-甲基黄嘌呤(磷酸二酯酶抑制剂)对大鼠非甾体抗炎药所致胃损伤的预防作用
Dig Dis Sci. 2003 May;48(5):986-91. doi: 10.1023/a:1023020201005.
2
Effects of PDE4 inhibitors on lipopolysaccharide-induced priming of superoxide anion production from human mononuclear cells.磷酸二酯酶4抑制剂对脂多糖诱导人单核细胞超氧阴离子产生启动的影响。
Mediators Inflamm. 2001 Jun;10(3):117-23. doi: 10.1080/09629350123856.
3
Relaxation of guinea-pig trachea by cyclic AMP phosphodiesterase inhibitors and their enhancement by sodium nitroprusside.环磷酸腺苷磷酸二酯酶抑制剂对豚鼠气管的舒张作用及其被硝普钠增强的作用
Br J Pharmacol. 1994 Apr;111(4):1047-52. doi: 10.1111/j.1476-5381.1994.tb14850.x.

本文引用的文献

1
Platelet activating factor (PAF) induces the oxidative burst in macrophages.血小板活化因子(PAF)可诱导巨噬细胞产生氧化爆发。
Int J Immunopharmacol. 1983;5(2):115-21. doi: 10.1016/0192-0561(83)90002-4.
2
Functional antagonism in canine tracheal smooth muscle: inhibition by methacholine of the mechanical and biochemical responses to isoproterenol.犬气管平滑肌中的功能性拮抗作用:乙酰甲胆碱对异丙肾上腺素的机械和生化反应的抑制作用。
J Pharmacol Exp Ther. 1983 Dec;227(3):694-9.
3
Inhibitory action of elevated levels of adenosine-3':5' cyclic monophosphate on phagocytosis: effects on macrophage-Trypanosoma cruzi interaction.腺苷-3':5'-环磷酸水平升高对吞噬作用的抑制作用:对巨噬细胞-克氏锥虫相互作用的影响。
J Immunol. 1982 Dec;129(6):2759-62.
4
The role of agonists that activate adenylate cyclase in the control of cAMP metabolism and enzyme release by human polymorphonuclear leukocytes.激活腺苷酸环化酶的激动剂在人多形核白细胞控制环磷酸腺苷代谢和酶释放中的作用。
J Immunol. 1980 Nov;125(5):2277-83.
5
The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors.人及豚鼠心室中一种新型环核苷酸磷酸二酯酶活性的鉴定。对选择性磷酸二酯酶抑制剂作用机制的启示。
Biochem J. 1987 Jan 15;241(2):535-41. doi: 10.1042/bj2410535.
6
The alveolar macrophage.肺泡巨噬细胞。
J Appl Physiol (1985). 1986 Feb;60(2):353-69. doi: 10.1152/jappl.1986.60.2.353.
7
Adenosine; a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils.腺苷;人类中性粒细胞超氧阴离子生成的生理调节剂。腺苷通过人类中性粒细胞上的A2受体发挥作用。
J Immunol. 1985 Aug;135(2):1366-71.
8
A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity.新一代磷酸二酯酶抑制剂:磷酸二酯酶的多种分子形式及药物选择性潜力
J Med Chem. 1985 May;28(5):537-45. doi: 10.1021/jm50001a001.
9
Human alveolar macrophage activation: inhibition by forskolin but not beta-adrenoceptor stimulation or phosphodiesterase inhibition.
Pulm Pharmacol. 1988;1(2):101-6. doi: 10.1016/s0952-0600(88)80006-1.
10
Multiple isozymes of cyclic nucleotide phosphodiesterase.环核苷酸磷酸二酯酶的多种同工酶。
Adv Second Messenger Phosphoprotein Res. 1988;22:1-38.